Verrica Pharmaceuticals Inc. 与 Medomie Pharma已签署一项独家分销、营销及供应协议，旨在以色列市场推出Ycanth®，用于治疗传染性软疣。该协议授权Medomie Pharma在以色列境内独家负责Ycanth®的商业化活动，包括分销、市场推广及供应链管理。Ycanth®是Verrica公司开发的一款针对传染性软疣的处方疗法。此次合作旨在扩大该疗法在中东地区的可及性，满足当地患者的医疗需求。
Verrica Pharmaceuticals Inc. 与 Medomie Pharma已签署一项独家分销、营销及供应协议，旨在以色列市场推出Ycanth®，用于治疗传染性软疣。该协议授权Medomie Pharma在以色列境内独家负责Ycanth®的商业化活动，包括分销、市场推广及供应链管理。Ycanth®是Verrica公司开发的一款针对传染性软疣的处方疗法。此次合作旨在扩大该疗法在中东地区的可及性，满足当地患者的医疗需求。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.